Egalet Notified that FDA Will Not Meet PDUFA Goal Date for Arymo ER

WAYNE, Pa., Oct. 13, 2016 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ( " Egalet " ), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions,...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news